USDA seeking contractors for avian influenza vaccines
According to the announcement, this procurement is to ensure that the National Veterinary Stockpile (NVS) is able to be utilized in case of the Eurasian highly pathogenic avian influenza virus reaching high levels of infection in certain states or nationally.
Products that are sought include completed vaccines with a shelf life exceeding one year and precursors that are within development and that could be processed into finished vaccines. These contracts would take the form of indefinite-delivery indefinite quantity (IDIQ) agreements to support the NVS on a continual basis.
All contracts will be worth a minimum of $6 million for up to 500 million doses.
For contracting purposes, vaccines or vaccine precursors will need to be fully licensed, products must be packaged and stored in a way that maximizes its viability and must be within Center for Veterinary Biologics (CVB) regulations in order to be administered throughout the U.S. Samples of the vaccines or samples from vaccinated animals will also be provided to the CVB, if requested.
The primary point of contact for this contract is Contracting Officer for APHIS Jim Roloff, who can be reached at email@example.com.